Inpatient admissions: Acute inpatient; acute rehabilitation; long term acute care hospital (LTACH); OB delivery stays beyond the federal minimum (including newborn stays beyond mother’s stay); skilled nursing facility. For emergency care admissions, precertification is not required but plan notification should be provided as soon as possible.
Diagnostic testing: Breast cancer (BRCA) genetic testing; gene expression profiling for breast cancer management; chromosomal microarray analysis (CMA) for developmental delay/autism/intellectual disability/congenital anomalies; gene mutation testing for cancer susceptibility and management; genetic testing for Lynch syndrome, FAP/attenuated FAP, MYH-associated polyposis; genetic testing for inherited diseases; preimplantation genetic diagnosis; testing for biochemical markers for Alzheimer’s disease; prostate saturation biopsy; whole genome sequencing, whole exome sequencing, gene panels, molecular profiling; wireless capsule for evaluation of suspected gastric and intestinal motility disorders.
Durable medical equipment/prosthetics: Functional electrical stimulation (FES)/threshold electrical stimulation (TES); high-frequency chest compression devices; intrapulmonary percussive ventilation devices; implantable infusion pumps; microprocessor controlled knee-ankle-foot orthosis; myoelectric upper extremity prosthetics; microprocessor controlled lower limb prosthesis; neuromuscular electrical training for obstructive sleep apnea/snoring; robotic arm assistive devices; noninvasive electrical bone growth stimulation of the appendicular skeleton; standing frames; ultrasonic diathermy devices; ultrasound bone growth stimulation; powered wheeled mobility devices.
Transplants, cellular/gene therapies, and related therapies: All transplant procedures and transplant-related services (outpatient and inpatient) including solid organ and bone marrow/stem cell transplants (including kidney-only), donor leukocyte infusion, CAR T-cell therapies (examples listed in policy), and stem cell/bone marrow transplant with or without myeloablative therapy. Gene replacement/therapy requires confirmation if group has excluded the benefit; if covered, pre-certification is required (examples listed: Zolgensma, Luxturna, therapies for hemophilia, CALD, beta thalassemia, Duchenne, metachromatic leukodystrophy, sickle cell disease).
Mental health and substance abuse (MHSA): Acute inpatient admissions; transcranial magnetic stimulation (TMS); residential care; behavioral health in-home programs; applied behavioral analysis (ABA) (precertification recommended and applies unless the group opts out; retrospective review allowed); intensive outpatient therapy (IOP); partial hospitalization (PHP). Check benefits for exclusions or specific precertification requirements.
Other outpatient and surgical services: Includes but is not limited to: Aduhelm (aducanumab); ambulance services (air and water, excludes 911-initiated emergency transport); ablative techniques for Barrett’s esophagus; allogeneic/xenographic/synthetic/bioengineered/composite wound healing and soft tissue grafting products; insertion/injection of prosthetic material (collagen implants); axial lumbar interbody fusion; balloon sinus ostial dilation; bariatric surgery and other treatments for clinically severe obesity (if covered, pre-certification is required); blepharoplasty/blepharoptosis repair/brow lift; breast procedures including reconstructive surgery and implants; bone-anchored and bone conduction hearing aids; bronchial thermoplasty; cardiac resynchronization therapy (CRT) with/without ICD; cardiac contractility modulation therapy; carotid/vertebral/intracranial artery stent placement; cardioverter defibrillators; cochlear and auditory brainstem implants; cosmetic and reconstructive head/neck procedures; minimally invasive posterior nasal nerve treatment for rhinitis; oral/pharyngeal/maxillofacial surgery for OSA/snoring; nasal surgery for OSA/snoring; outpatient cardiac hemodynamic monitoring using wireless sensor; panniculectomy/abdominoplasty; partial left ventriculectomy; PFO and left atrial appendage closure devices; penile prosthesis implantation; percutaneous and endoscopic spinal surgery; percutaneous neurolysis for chronic neck/back pain; perirectal spacers for prostate radiotherapy; vertebroplasty/kyphoplasty/sacroplasty; presbyopia/astigmatism-correcting intraocular lenses; private duty nursing in the home; reduction mammaplasty; sacral nerve stimulation/PTNS; sacral nerve stimulation for neurogenic bladder; sacroiliac joint fusion (open); Sipuleucel-T; surgical/ablative treatments for chronic headaches; therapeutic apheresis; total ankle replacement; transcatheter ablation for pulmonary vein foci; transcatheter heart valve procedures; transendoscopic therapy for GERD/dysphagia/gastroparesis; transmyocardial/perventricular device closure of VSD; treatment of osteochondral defects; treatment of temporomandibular disorders.
Radiation therapy and radiology services: Absolute quantitation of myocardial blood flow measurement; catheter-based embolization procedures for malignant lesions outside the liver; cryosurgical or radiofrequency ablation for solid tumors outside the liver; MRI-guided high intensity focused ultrasound ablation for non-oncologic indications; intensity modulated radiation therapy (IMRT); proton beam therapy; radioimmunotherapy and somatostatin receptor targeted radiotherapy (Azedra, Lutathera, Pluvicto, Zevalin); stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT); wireless capsule endoscopy for GI imaging and patency capsule; Xofigo (radium Ra 223 dichloride).
Out-of-network referrals: Out-of-network services may be authorized at in-network benefit level based on network availability and/or medical necessity.